Chief Scientific Officer Stephen Betz of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 3,000 shares of the company on January 10, 2024, according to a recent SEC Filing.
Chief Med and Dev Officer Dana Pizzuti of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 14,375 shares of the company on January 3, 2024, according to a recent SEC filing.
On December 26, 2023, Stephen Betz, Chief Scientific Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), sold 3,000 shares of the company's stock, according to a recent SEC Filing.